data_1gdf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gdf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.142 0.496 . . . . 11.52 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.69 28.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.554 -0.716 . . . . 10.66 110.11 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.7 t -167.8 148.51 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.43 -0.794 . . . . 9.5500000000000007 110.202 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.94 29.9 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.566 -0.709 . . . . 8.8000000000000007 110.269 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.68 85.99 0.17 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.434 -0.791 . . . . 8.1500000000000004 110.747 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.27 -5.73 17.65 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.52 1.274 . . . . 6.2000000000000002 111.375 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 m120 53.77 69.97 0.65 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.039 -1.038 . . . . 5.4699999999999998 110.545 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.3 m -59.44 111.15 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.595 -0.69 . . . . 4.4400000000000004 110.409 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.47 164.64 33.49 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 122.973 0.986 . . . . 2.6800000000000002 110.218 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -86.65 -66.25 0.93 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.543 -0.723 . . . . 1.71 110.094 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 189' ' ' HIS . 87.4 t -130.74 121.71 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.699 -0.625 . . . . 1.28 110.287 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.1 t -143.59 144.69 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.781 -0.575 . . . . 1.22 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 ' CG2' ' CG ' ' A' ' 181' ' ' PHE . 54.3 t -62.75 105.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.572 -0.705 . . . . 1.1200000000000001 109.666 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.0 p -72.42 -50.37 26.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 1.1699999999999999 110.097 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -149.07 169.56 20.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.64 -0.663 . . . . 2.8599999999999999 110.348 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.6 tt -135.78 122.04 20.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.66 . . . . 1.25 109.708 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 m -109.9 162.78 14.17 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 1.1799999999999999 110.65 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.19 101.05 3.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 1.3500000000000001 110.053 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.23 166.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.621 -0.674 . . . . 1.3999999999999999 110.329 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.3 -166.34 1.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 2.0299999999999998 109.975 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.5 p -101.53 -29.51 11.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.573 -0.704 . . . . 2.1699999999999999 110.205 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 p -132.98 33.95 3.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 1.4099999999999999 110.191 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 202' ' ' TRP . . . -90.43 163.74 29.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 1.3300000000000001 110.467 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.41 -26.53 24.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.438 1.23 . . . . 0.71999999999999997 110.275 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.03 172.35 32.38 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.035 -1.226 . . . . 0.57999999999999996 110.035 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.46 99.55 1.05 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.506 1.266 . . . . 0.59999999999999998 110.35 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 9.9 mt -64.86 122.51 17.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 1.3799999999999999 109.717 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.32 123.66 48.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 1.8100000000000001 110.713 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD2' ' CZ ' ' A' ' 97' ' ' PHE . 2.3 mt -106.48 143.84 34.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.594 -0.691 . . . . 1.71 109.724 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 1.8 t70 -87.22 129.33 35.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.576 -0.702 . . . . 1.3300000000000001 110.704 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD22 ' CD2' ' A' ' 192' ' ' TRP . 0.8 OUTLIER -129.48 50.11 2.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -0.761 . . . . 1.26 110.152 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -118.37 -65.66 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 1.4399999999999999 110.287 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.14 -54.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.646 -1.382 . . . . 1.1699999999999999 109.646 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.67 70.38 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.556 -0.967 . . . . 2.5800000000000001 110.147 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 97' ' ' PHE . 7.9 mt -95.21 -22.09 18.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 1.73 110.676 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.34 -26.33 52.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.374 -0.828 . . . . 3.0600000000000001 110.824 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 t -64.73 -18.17 64.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.477 -0.764 . . . . 1.8100000000000001 110.768 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.446 ' CZ ' ' CD2' ' A' ' 88' ' ' LEU . 4.8 m-85 -58.84 -52.37 66.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 2.52 110.549 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -65.68 -13.26 58.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.722 . . . . 2.5499999999999998 111.093 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -86.67 -25.36 24.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 3.1899999999999999 110.613 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -131.28 159.36 38.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 2.46 110.52 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 p -124.58 -171.51 2.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.599 -0.688 . . . . 1.0800000000000001 110.22 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.42 ' CE1' ' CD1' ' A' ' 88' ' ' LEU . 2.2 m-85 -116.76 112.63 21.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 1.8999999999999999 109.854 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.07 136.31 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 1.3300000000000001 110.282 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' HA ' ' CE3' ' A' ' 202' ' ' TRP . 12.6 mt -147.49 -177.55 5.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.615 -0.678 . . . . 2.0899999999999999 110.017 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 202' ' ' TRP . 0.5 OUTLIER -110.75 167.38 10.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.689 . . . . 2.48 109.407 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -50.27 105.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.803 0.811 . . . . 1.9299999999999999 111.918 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 67.2 1.87 Allowed Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.878 -0.513 . . . . 1.49 112.609 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 105' ' ' LYS . 28.4 m -87.28 143.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.281 -1.129 . . . . 1.3400000000000001 109.872 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -83.6 92.13 7.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.476 -0.765 . . . . 2.0699999999999998 109.212 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -113.67 151.9 31.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.546 -0.721 . . . . 2.25 111.523 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -102.74 165.91 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.141 -0.688 . . . . 2.7200000000000002 109.141 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.9 mt -125.97 133.05 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.257 -0.902 . . . . 1.4299999999999999 110.445 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -115.94 103.83 11.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.681 -0.637 . . . . 2.3599999999999999 109.775 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.0 mm -91.97 138.07 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 1.1499999999999999 110.166 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.2 m -120.13 141.54 49.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.732 -0.84 . . . . 1.3999999999999999 108.732 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.448 ' CD2' ' CE ' ' A' ' 126' ' ' MET . 25.6 p90 -155.66 135.44 12.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.433 -0.792 . . . . 1.8899999999999999 110.952 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -79.27 143.19 35.49 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.25 0.547 . . . . 2.7000000000000002 111.246 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 56.7 t -131.22 89.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 109.171 -0.677 . . . . 1.26 109.171 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.84 48.57 2.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.492 -0.755 . . . . 3.4700000000000002 111.174 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.45 -66.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 3.4399999999999999 110.509 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.18 165.71 27.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 2.2599999999999998 110.589 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 122' ' ' ILE . 80.8 mt -80.22 113.96 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.749 -0.594 . . . . 1.6699999999999999 110.199 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 64.2 t -94.21 89.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 1.29 109.63 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.1 p -83.24 105.05 13.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 1.48 110.382 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.65 44.06 0.36 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.761 -1.336 . . . . 0.46999999999999997 109.761 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.47 ' CE ' ' CE2' ' A' ' 181' ' ' PHE . 0.8 OUTLIER -76.34 144.13 40.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -1.0 . . . . 1.3700000000000001 109.854 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -137.47 148.29 45.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 2.0800000000000001 110.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -124.14 103.1 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.283 -0.636 . . . . 1.1399999999999999 109.283 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 77.0 mt -96.4 166.24 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 1.5700000000000001 110.296 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.405 ' CG ' ' CG2' ' A' ' 177' ' ' ILE . 36.0 tt0 -162.12 119.26 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.608 . . . . 1.71 109.802 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.8 m-70 -104.19 120.53 41.33 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -0.804 . . . . 0.78000000000000003 110.072 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -77.06 87.12 3.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.684 . . . . 1.2 109.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 2.6 m-85 -81.21 131.66 35.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -0.769 . . . . 1.1200000000000001 110.133 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -120.92 116.88 25.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 3.6499999999999999 110.099 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt 53.02 37.44 24.72 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.398 -0.814 . . . . 4.5099999999999998 110.678 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.39 34.85 39.11 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.587 -1.405 . . . . 1.4199999999999999 109.587 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 58.8 t -147.18 111.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.51 -0.994 . . . . 2.3199999999999998 110.079 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.7 129.87 41.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.552 -0.718 . . . . 3.1899999999999999 110.206 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.98 -22.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 2.0699999999999998 110.682 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.09 132.81 1.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 2.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 4.2 pttt -141.33 143.61 34.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 2.5299999999999998 109.912 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.0 m -139.29 167.66 21.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.437 -0.79 . . . . 1.97 110.712 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -118.68 117.08 27.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.67 -0.644 . . . . 2.3199999999999998 110.125 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.95 106.97 19.0 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.464 -0.772 . . . . 2.3700000000000001 110.426 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ttt -66.24 113.82 4.86 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 2.7400000000000002 109.61 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' HA ' ' CE1' ' A' ' 158' ' ' PHE . 54.1 t -79.73 -66.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.552 -0.717 . . . . 1.3300000000000001 110.059 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.37 173.96 19.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.847 -1.301 . . . . 0.85999999999999999 109.847 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -83.33 149.82 26.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.676 -0.896 . . . . 1.5 110.07 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -147.55 125.9 12.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.579 -0.701 . . . . 1.8999999999999999 110.301 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -101.13 147.41 17.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.438 -1.465 . . . . 0.80000000000000004 109.438 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.25 141.0 34.91 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.34 1.179 . . . . 1.05 110.263 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -167.1 -39.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.637 -0.664 . . . . 4.9699999999999998 110.899 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.37 -75.2 0.43 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 3.5099999999999998 111.365 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.37 -145.0 0.16 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.413 -0.805 . . . . 3.6899999999999999 110.473 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.406 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . 1.8 pm0 -83.37 -175.07 5.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.169 -0.957 . . . . 2.5299999999999998 111.068 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 51.4 m-85 -127.21 171.83 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.406 -0.591 . . . . 2.54 109.406 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -123.24 96.99 5.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 2.2799999999999998 110.96 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.419 ' CE2' HG23 ' A' ' 160' ' ' THR . 37.9 t80 -76.89 162.04 27.93 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.895 -0.78 . . . . 2.5800000000000001 108.895 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.5 mt -148.82 124.54 10.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.376 -0.827 . . . . 2.3799999999999999 110.865 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.419 HG23 ' CE2' ' A' ' 158' ' ' PHE . 42.0 p -102.27 152.53 38.3 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.557 -0.714 . . . . 1.23 109.333 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.54 169.3 16.05 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.584 1.308 . . . . 0.53000000000000003 110.631 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -57.8 114.81 2.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.654 -0.654 . . . . 3.3700000000000001 110.808 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -105.22 109.78 21.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.69 . . . . 2.0 109.815 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -66.11 128.92 37.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 2.4700000000000002 110.501 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -77.22 -176.83 0.68 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.762 -0.586 . . . . 1.23 109.844 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 126.27 9.48 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.164 1.087 . . . . 0.83999999999999997 110.247 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -111.06 172.71 6.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.515 -0.741 . . . . 2.7400000000000002 110.412 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.23 156.59 9.72 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.428 -1.469 . . . . 2.1699999999999999 109.428 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.9 ttt -60.33 -39.78 88.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.563 -0.963 . . . . 3.23 110.114 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 tt -82.4 -25.15 33.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.666 -0.646 . . . . 3.1299999999999999 110.29 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.74 -22.58 58.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.735 . . . . 1.3400000000000001 110.72 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -64.88 126.29 27.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.379 -0.826 . . . . 2.75 110.008 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.08 -178.58 30.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.733 -1.347 . . . . 0.53000000000000003 109.733 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.0 p -85.0 137.42 33.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.622 -0.928 . . . . 0.84999999999999998 110.575 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.96 103.76 8.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.65 -0.656 . . . . 1.1799999999999999 110.428 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.34 129.97 41.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.566 -0.709 . . . . 1.8700000000000001 109.328 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 25.1 mt -118.58 150.15 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.376 -0.827 . . . . 1.3200000000000001 110.798 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -119.0 104.74 10.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.621 -0.674 . . . . 3.0099999999999998 110.199 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 1.9 m -104.46 124.31 49.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.77 110.169 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -113.93 108.46 17.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 2.8900000000000001 110.113 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.47 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.3 t80 -80.88 104.38 11.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.703 -0.623 . . . . 2.3900000000000001 109.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t -130.76 -171.8 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 1.6699999999999999 110.353 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.45 -151.18 0.47 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.583 . . . . 1.52 109.427 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.24 -49.63 76.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 2.8700000000000001 110.248 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.25 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.914 -0.491 . . . . 5.0800000000000001 112.074 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.4 -50.1 23.3 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.046 -1.034 . . . . 6.4100000000000001 111.819 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -175.93 -166.29 0.18 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.731 . . . . 1.79 110.758 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -115.12 125.21 53.2 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.388 -0.597 . . . . 2.5899999999999999 109.388 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.418 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 57.9 m-70 -69.31 -56.42 7.58 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.501 -0.75 . . . . 2.4500000000000002 110.732 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 12.2 tp -168.52 154.6 6.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.814 . . . . 1.8300000000000001 110.444 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -146.48 142.04 27.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.617 -0.677 . . . . 1.52 109.974 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 179' ' ' SER . 24.3 p90 -137.42 -163.89 1.51 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.565 -0.71 . . . . 0.40999999999999998 110.139 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.66 126.11 7.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.536 -0.728 . . . . 2.4900000000000002 110.545 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 194' ' ' TRP . 9.0 p-90 -137.36 146.12 44.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.632 -0.668 . . . . 0.45000000000000001 109.893 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.08 143.78 25.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.708 -0.62 . . . . 1.9099999999999999 111.1 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 17.7 tp -111.26 104.8 13.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.729 -0.607 . . . . 1.3799999999999999 109.454 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.2 m -81.89 107.17 14.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.62 -0.675 . . . . 1.1299999999999999 110.805 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.0 mm -78.81 159.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.582 -0.698 . . . . 1.22 109.27 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -154.93 -154.24 0.49 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.807 . . . . 2.5299999999999998 110.369 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -122.85 -34.41 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.745 . . . . 4.1200000000000001 111.025 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -143.19 51.56 1.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 2.6200000000000001 111.772 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TRP . . . . . 0.443 ' CE3' ' HA ' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -55.27 -21.92 16.4 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.89000000000000001 110.986 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.31 37.47 1.77 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 4.25 110.054 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.033 -0.984 . . . . 3.7400000000000002 110.184 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.142 0.496 . . . . 11.17 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 61' ' ' VAL . 8.9 p -121.69 28.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.554 -0.716 . . . . 10.220000000000001 110.11 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.7 t -167.8 148.51 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.43 -0.794 . . . . 9.1600000000000001 110.202 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.94 29.9 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.566 -0.709 . . . . 8.4299999999999997 110.269 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.68 85.99 0.17 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.434 -0.791 . . . . 8.1500000000000004 110.747 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.27 -5.73 17.65 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.52 1.274 . . . . 5.6299999999999999 111.375 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 m120 53.77 69.97 0.65 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.039 -1.038 . . . . 5.0099999999999998 110.545 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 67' ' ' VAL . 35.3 m -59.44 111.15 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.595 -0.69 . . . . 4.0599999999999996 110.409 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.47 164.64 33.49 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 122.973 0.986 . . . . 2.3199999999999998 110.218 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 70' ' ' VAL . 59.5 t-20 -86.65 -66.25 0.93 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.543 -0.723 . . . . 1.6200000000000001 110.094 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 123' ' ' VAL . 87.4 t -130.74 121.71 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.699 -0.625 . . . . 0.93000000000000005 110.287 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.1 t -143.59 144.69 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.781 -0.575 . . . . 0.46999999999999997 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 90' ' ' LEU . 54.3 t -62.75 105.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.572 -0.705 . . . . 0.42999999999999999 109.666 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 116' ' ' PHE . 47.0 p -72.42 -50.37 26.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 0.46000000000000002 110.097 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -149.07 169.56 20.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.64 -0.663 . . . . 2.46 110.348 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -135.78 122.04 20.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.66 . . . . 0.56000000000000005 109.708 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 m -109.9 162.78 14.17 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.51000000000000001 110.65 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.19 101.05 3.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.66000000000000003 110.053 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.9 t -98.23 166.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.621 -0.674 . . . . 0.80000000000000004 110.329 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.3 -166.34 1.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 1.5600000000000001 109.975 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.5 p -101.53 -29.51 11.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.573 -0.704 . . . . 1.8200000000000001 110.205 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 p -132.98 33.95 3.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 1.02 110.191 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.43 163.74 29.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.69999999999999996 110.467 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 44.0 Cg_endo -70.41 -26.53 24.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.438 1.23 . . . . 0.62 110.275 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.03 172.35 32.38 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.035 -1.226 . . . . 0.51000000000000001 110.035 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.46 99.55 1.05 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.506 1.266 . . . . 0.55000000000000004 110.35 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 9.9 mt -64.86 122.51 17.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.73999999999999999 109.717 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.32 123.66 48.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 1.8100000000000001 110.713 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.915 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 2.3 mt -106.48 143.84 34.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.594 -0.691 . . . . 1.05 109.724 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 1.8 t70 -87.22 129.33 35.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.576 -0.702 . . . . 1.3300000000000001 110.704 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -129.48 50.11 2.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -0.761 . . . . 0.65000000000000002 110.152 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -118.37 -65.66 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.96999999999999997 110.287 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.14 -54.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.646 -1.382 . . . . 0.91000000000000003 109.646 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.67 70.38 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.556 -0.967 . . . . 2.5800000000000001 110.147 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.466 HD23 ' CE1' ' A' ' 97' ' ' PHE . 7.9 mt -95.21 -22.09 18.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 1.1699999999999999 110.676 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.34 -26.33 52.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.374 -0.828 . . . . 3.0600000000000001 110.824 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 t -64.73 -18.17 64.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.477 -0.764 . . . . 1.48 110.768 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.915 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 4.8 m-85 -58.84 -52.37 66.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 1.6799999999999999 110.549 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -65.68 -13.26 58.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.722 . . . . 2.21 111.093 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -86.67 -25.36 24.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 2.6800000000000002 110.613 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -131.28 159.36 38.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 2.46 110.52 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 p -124.58 -171.51 2.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.599 -0.688 . . . . 0.87 110.22 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.2 m-85 -116.76 112.63 21.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 1.3100000000000001 109.854 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.07 136.31 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.75 110.282 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 108' ' ' VAL . 12.6 mt -147.49 -177.55 5.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.615 -0.678 . . . . 1.49 110.017 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -110.75 167.38 10.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.689 . . . . 1.96 109.407 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -50.27 105.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.803 0.811 . . . . 1.9299999999999999 111.918 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 67.2 1.87 Allowed Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.878 -0.513 . . . . 0.80000000000000004 112.609 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 104' ' ' LEU . 28.4 m -87.28 143.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.281 -1.129 . . . . 0.81000000000000005 109.872 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -83.6 92.13 7.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.476 -0.765 . . . . 2.0699999999999998 109.212 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.677 ' HD2' HG23 ' A' ' 108' ' ' VAL . 39.6 p90 -113.67 151.9 31.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.546 -0.721 . . . . 1.46 111.523 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -102.74 165.91 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.141 -0.688 . . . . 2.2799999999999998 109.141 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.9 mt -125.97 133.05 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.257 -0.902 . . . . 0.65000000000000002 110.445 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -115.94 103.83 11.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.681 -0.637 . . . . 1.77 109.775 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.0 mm -91.97 138.07 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 0.40999999999999998 110.166 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.2 m -120.13 141.54 49.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.732 -0.84 . . . . 1.1299999999999999 108.732 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.7 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -155.66 135.44 12.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.433 -0.792 . . . . 1.1599999999999999 110.952 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -79.27 143.19 35.49 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.25 0.547 . . . . 2.23 111.246 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 70' ' ' VAL . 56.7 t -131.22 89.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 109.171 -0.677 . . . . 0.65000000000000002 109.171 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.84 48.57 2.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.492 -0.755 . . . . 2.7799999999999998 111.174 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.45 -66.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 2.9399999999999999 110.509 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.18 165.71 27.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 2.23 110.589 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.8 mt -80.22 113.96 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.749 -0.594 . . . . 1.01 110.199 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 70' ' ' VAL . 64.2 t -94.21 89.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.75 109.63 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.1 p -83.24 105.05 13.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 1.1100000000000001 110.382 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.65 44.06 0.36 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.761 -1.336 . . . . 0.44 109.761 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.482 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -76.34 144.13 40.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -1.0 . . . . 1.22 109.854 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -137.47 148.29 45.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 1.5 110.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -124.14 103.1 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.283 -0.636 . . . . 0.78000000000000003 109.283 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 130' ' ' GLN . 77.0 mt -96.4 166.24 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.97999999999999998 110.296 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 129' ' ' ILE . 36.0 tt0 -162.12 119.26 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.608 . . . . 1.71 109.802 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.8 m-70 -104.19 120.53 41.33 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -0.804 . . . . 0.64000000000000001 110.072 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -77.06 87.12 3.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.684 . . . . 0.55000000000000004 109.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 2.6 m-85 -81.21 131.66 35.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -0.769 . . . . 0.89000000000000001 110.133 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -120.92 116.88 25.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 3.1099999999999999 110.099 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt 53.02 37.44 24.72 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.398 -0.814 . . . . 4.04 110.678 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 77.39 34.85 39.11 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.587 -1.405 . . . . 1.4199999999999999 109.587 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.419 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.8 t -147.18 111.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.51 -0.994 . . . . 1.72 110.079 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.7 129.87 41.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.552 -0.718 . . . . 2.8199999999999998 110.206 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.98 -22.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 1.47 110.682 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.09 132.81 1.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 2.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 4.2 pttt -141.33 143.61 34.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 2.1200000000000001 109.912 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 143' ' ' ASP . 37.0 m -139.29 167.66 21.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.437 -0.79 . . . . 1.4199999999999999 110.712 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 142' ' ' THR . 10.0 p-10 -118.68 117.08 27.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.67 -0.644 . . . . 2.3199999999999998 110.125 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.95 106.97 19.0 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.464 -0.772 . . . . 1.52 110.426 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ttt -66.24 113.82 4.86 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 2.23 109.61 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 158' ' ' PHE . 54.1 t -79.73 -66.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.552 -0.717 . . . . 0.93000000000000005 110.059 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.37 173.96 19.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.847 -1.301 . . . . 0.80000000000000004 109.847 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -83.33 149.82 26.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.676 -0.896 . . . . 1.3600000000000001 110.07 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.46 ' CE2' HG12 ' A' ' 146' ' ' VAL . 77.9 m-85 -147.55 125.9 12.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.579 -0.701 . . . . 1.26 110.301 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -101.13 147.41 17.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.438 -1.465 . . . . 0.70999999999999996 109.438 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.25 141.0 34.91 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.34 1.179 . . . . 1.05 110.263 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -167.1 -39.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.637 -0.664 . . . . 4.5800000000000001 110.899 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.37 -75.2 0.43 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 3.0699999999999998 111.365 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.37 -145.0 0.16 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.413 -0.805 . . . . 3.6899999999999999 110.473 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.435 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . 1.8 pm0 -83.37 -175.07 5.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.169 -0.957 . . . . 2.5299999999999998 111.068 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 51.4 m-85 -127.21 171.83 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.406 -0.591 . . . . 1.6399999999999999 109.406 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -123.24 96.99 5.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 2.2799999999999998 110.96 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 146' ' ' VAL . 37.9 t80 -76.89 162.04 27.93 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.895 -0.78 . . . . 1.6399999999999999 108.895 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.5 mt -148.82 124.54 10.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.376 -0.827 . . . . 1.75 110.865 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.472 HG22 ' CE2' ' A' ' 158' ' ' PHE . 42.0 p -102.27 152.53 38.3 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.557 -0.714 . . . . 0.60999999999999999 109.333 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.54 169.3 16.05 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.584 1.308 . . . . 0.47999999999999998 110.631 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -57.8 114.81 2.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.654 -0.654 . . . . 2.79 110.808 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -105.22 109.78 21.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.69 . . . . 2.0 109.815 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -66.11 128.92 37.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 2.4700000000000002 110.501 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.855 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.22 -176.83 0.68 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.762 -0.586 . . . . 0.60999999999999999 109.844 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.855 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.5 Cg_endo -75.6 126.27 9.48 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.164 1.087 . . . . 0.83999999999999997 110.247 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 10.6 ptpt -111.06 172.71 6.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.515 -0.741 . . . . 2.29 110.412 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.23 156.59 9.72 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.428 -1.469 . . . . 1.7 109.428 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.9 ttt -60.33 -39.78 88.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.563 -0.963 . . . . 2.8500000000000001 110.114 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 170' ' ' LEU . 3.6 tt -82.4 -25.15 33.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.666 -0.646 . . . . 2.5499999999999998 110.29 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -58.74 -22.58 58.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.735 . . . . 0.77000000000000002 110.72 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -64.88 126.29 27.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.379 -0.826 . . . . 2.2999999999999998 110.008 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.08 -178.58 30.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.733 -1.347 . . . . 0.46999999999999997 109.733 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.0 p -85.0 137.42 33.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.622 -0.928 . . . . 0.47999999999999998 110.575 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.96 103.76 8.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.65 -0.656 . . . . 0.59999999999999998 110.428 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.435 ' OD1' ' ND2' ' A' ' 195' ' ' ASN . 1.7 t30 -66.34 129.97 41.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.566 -0.709 . . . . 1.52 109.328 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 25.1 mt -118.58 150.15 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.376 -0.827 . . . . 0.80000000000000004 110.798 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -119.0 104.74 10.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.621 -0.674 . . . . 2.4399999999999999 110.199 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 1.9 m -104.46 124.31 49.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.3500000000000001 110.169 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -113.93 108.46 17.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 2.46 110.113 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.47 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.3 t80 -80.88 104.38 11.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.703 -0.623 . . . . 1.5800000000000001 109.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t -130.76 -171.8 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 1.1699999999999999 110.353 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.45 -151.18 0.47 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.583 . . . . 1.52 109.427 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.24 -49.63 76.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 2.8700000000000001 110.248 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.25 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.914 -0.491 . . . . 5.0800000000000001 112.074 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.4 -50.1 23.3 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.046 -1.034 . . . . 5.7699999999999996 111.819 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -175.93 -166.29 0.18 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.731 . . . . 1.46 110.758 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -115.12 125.21 53.2 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.388 -0.597 . . . . 2.5899999999999999 109.388 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.427 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 57.9 m-70 -69.31 -56.42 7.58 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.501 -0.75 . . . . 1.8300000000000001 110.732 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 12.2 tp -168.52 154.6 6.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.814 . . . . 1.3100000000000001 110.444 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -146.48 142.04 27.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.617 -0.677 . . . . 1.3 109.974 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.579 ' CD2' HD21 ' A' ' 90' ' ' LEU . 24.3 p90 -137.42 -163.89 1.51 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.565 -0.71 . . . . 0.38 110.139 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.66 126.11 7.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.536 -0.728 . . . . 2.4900000000000002 110.545 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.551 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 9.0 p-90 -137.36 146.12 44.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.632 -0.668 . . . . 0.40000000000000002 109.893 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' A' ' 176' ' ' ASN . 3.5 m-80 -93.08 143.78 25.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.708 -0.62 . . . . 1.28 111.1 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 104' ' ' LEU . 17.7 tp -111.26 104.8 13.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.729 -0.607 . . . . 0.77000000000000002 109.454 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.2 m -81.89 107.17 14.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.62 -0.675 . . . . 0.53000000000000003 110.805 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.0 mm -78.81 159.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.582 -0.698 . . . . 0.40000000000000002 109.27 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -154.93 -154.24 0.49 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.807 . . . . 2.0600000000000001 110.369 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -122.85 -34.41 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.745 . . . . 3.6499999999999999 111.025 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -143.19 51.56 1.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 2.6200000000000001 111.772 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TRP . . . . . 0.643 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -55.27 -21.92 16.4 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.81999999999999995 110.986 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.31 37.47 1.77 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 3.8700000000000001 110.054 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.033 -0.984 . . . . 3.7400000000000002 110.184 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.142 0.496 . . . . 11.17 110.171 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 61' ' ' VAL . 8.9 p -121.69 28.09 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.554 -0.716 . . . . 10.22 110.11 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.7 t -167.8 148.51 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.43 -0.794 . . . . 9.16 110.202 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.94 29.9 2.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.566 -0.709 . . . . 8.43 110.269 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 52.68 85.99 0.17 Allowed Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.434 -0.791 . . . . 8.15 110.747 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.27 -5.73 17.65 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.52 1.274 . . . . 5.63 111.375 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 34.5 m120 53.77 69.97 0.65 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.039 -1.038 . . . . 5.01 110.545 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 67' ' ' VAL . 35.3 m -59.44 111.15 3.39 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.595 -0.69 . . . . 4.06 110.409 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.47 164.64 33.49 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 O-C-N 122.973 0.986 . . . . 2.32 110.218 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' OD1' HG23 ' A' ' 70' ' ' VAL . 59.5 t-20 -86.65 -66.25 0.93 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.543 -0.723 . . . . 1.62 110.094 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 123' ' ' VAL . 87.4 t -130.74 121.71 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.699 -0.625 . . . . 0.93 110.287 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 62.1 t -143.59 144.69 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.781 -0.575 . . . . 0.47 109.812 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.646 ' CG1' HD13 ' A' ' 90' ' ' LEU . 54.3 t -62.75 105.76 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.572 -0.705 . . . . 0.43 109.666 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' HA ' ' A' ' 116' ' ' PHE . 47.0 p -72.42 -50.37 26.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.654 -0.654 . . . . 0.46 110.097 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -149.07 169.56 20.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.64 -0.663 . . . . 2.46 110.348 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 75' ' ' LEU . 9.6 tt -135.78 122.04 20.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.645 -0.66 . . . . 0.56 109.708 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 m -109.9 162.78 14.17 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.489 -0.757 . . . . 0.51 110.65 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.19 101.05 3.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.548 -0.72 . . . . 0.66 110.053 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 79' ' ' CYS . 58.9 t -98.23 166.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.621 -0.674 . . . . 0.8 110.329 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -160.3 -166.34 1.65 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 1.56 109.975 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 87.5 p -101.53 -29.51 11.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.573 -0.704 . . . . 1.82 110.205 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 p -132.98 33.95 3.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.621 -0.674 . . . . 1.02 110.191 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 79' ' ' CYS . . . -90.43 163.74 29.74 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.589 -0.694 . . . . 0.7 110.467 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' CZ3' ' A' ' 202' ' ' TRP . 44.0 Cg_endo -70.41 -26.53 24.42 Favored 'Trans proline' 0 C--N 1.316 -1.165 0 O-C-N 123.438 1.23 . . . . 0.62 110.275 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.03 172.35 32.38 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.035 -1.226 . . . . 0.51 110.035 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.46 99.55 1.05 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.506 1.266 . . . . 0.55 110.35 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 9.9 mt -64.86 122.51 17.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.633 -0.667 . . . . 0.74 109.717 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.32 123.66 48.24 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.566 -0.709 . . . . 1.81 110.713 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.915 HD22 ' CZ ' ' A' ' 97' ' ' PHE . 2.3 mt -106.48 143.84 34.01 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.594 -0.691 . . . . 1.05 109.724 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' O ' ' CE1' ' A' ' 97' ' ' PHE . 1.8 t70 -87.22 129.33 35.01 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.576 -0.702 . . . . 1.33 110.704 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.646 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.8 OUTLIER -129.48 50.11 2.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.482 -0.761 . . . . 0.65 110.152 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.7 p -118.37 -65.66 1.15 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.97 110.287 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -134.14 -54.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.646 -1.382 . . . . 0.91 109.646 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.67 70.38 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.556 -0.967 . . . . 2.58 110.147 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.466 HD23 ' CE1' ' A' ' 97' ' ' PHE . 7.9 mt -95.21 -22.09 18.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.526 -0.734 . . . . 1.17 110.676 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -56.34 -26.33 52.11 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.374 -0.828 . . . . 3.06 110.824 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 t -64.73 -18.17 64.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.477 -0.764 . . . . 1.48 110.768 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.915 ' CZ ' HD22 ' A' ' 88' ' ' LEU . 4.8 m-85 -58.84 -52.37 66.03 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.338 -0.851 . . . . 1.68 110.549 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -65.68 -13.26 58.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.544 -0.722 . . . . 2.21 111.093 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -86.67 -25.36 24.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 2.68 110.613 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -131.28 159.36 38.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.411 -0.806 . . . . 2.46 110.52 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.4 p -124.58 -171.51 2.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.599 -0.688 . . . . 0.87 110.22 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.616 ' CB ' HD12 ' A' ' 196' ' ' LEU . 2.2 m-85 -116.76 112.63 21.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 1.31 109.854 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.07 136.31 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.75 110.282 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.965 HD22 HG21 ' A' ' 108' ' ' VAL . 12.6 mt -147.49 -177.55 5.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.615 -0.678 . . . . 1.49 110.017 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HB3' ' CG1' ' A' ' 108' ' ' VAL . 0.5 OUTLIER -110.75 167.38 10.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.598 -0.689 . . . . 1.96 109.407 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -50.27 105.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.803 0.811 . . . . 1.93 111.918 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 49.51 67.2 1.87 Allowed Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.878 -0.513 . . . . 0.8 112.609 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.965 HG21 HD22 ' A' ' 104' ' ' LEU . 28.4 m -87.28 143.79 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.281 -1.129 . . . . 0.81 109.872 178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -83.6 92.13 7.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.476 -0.765 . . . . 2.07 109.212 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.677 ' HD2' HG23 ' A' ' 108' ' ' VAL . 39.6 p90 -113.67 151.9 31.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.546 -0.721 . . . . 1.46 111.523 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.1 mtt180 -102.74 165.91 10.79 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.141 -0.688 . . . . 2.28 109.141 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 69.9 mt -125.97 133.05 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.257 -0.902 . . . . 0.65 110.445 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -115.94 103.83 11.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.681 -0.637 . . . . 1.77 109.775 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.0 mm -91.97 138.07 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 0.41 110.166 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 41.2 m -120.13 141.54 49.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.732 -0.84 . . . . 1.13 108.732 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.7 ' HA ' HG23 ' A' ' 73' ' ' THR . 25.6 p90 -155.66 135.44 12.69 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.433 -0.792 . . . . 1.16 110.952 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.435 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 0.8 OUTLIER -79.27 143.19 35.49 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.25 0.547 . . . . 2.23 111.246 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 70' ' ' VAL . 56.7 t -131.22 89.96 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 109.171 -0.677 . . . . 0.65 109.171 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.84 48.57 2.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.492 -0.755 . . . . 2.78 111.174 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.45 -66.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 2.94 110.509 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -144.18 165.71 27.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.496 -0.752 . . . . 2.23 110.589 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 80.8 mt -80.22 113.96 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.749 -0.594 . . . . 1.01 110.199 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 70' ' ' VAL . 64.2 t -94.21 89.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.634 -0.666 . . . . 0.75 109.63 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 93.1 p -83.24 105.05 13.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 1.11 110.382 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 122.65 44.06 0.36 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.761 -1.336 . . . . 0.44 109.761 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.482 ' HE1' ' CG ' ' A' ' 116' ' ' PHE . 0.8 OUTLIER -76.34 144.13 40.35 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.5 -1.0 . . . . 1.22 109.854 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -137.47 148.29 45.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 1.5 110.849 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -124.14 103.1 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.283 -0.636 . . . . 0.78 109.283 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 130' ' ' GLN . 77.0 mt -96.4 166.24 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.98 110.296 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.466 ' N ' HG22 ' A' ' 129' ' ' ILE . 36.0 tt0 -162.12 119.26 2.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.728 -0.608 . . . . 1.71 109.802 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 13.8 m-70 -104.19 120.53 41.33 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.413 -0.804 . . . . 0.64 110.072 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.0 m -77.06 87.12 3.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.605 -0.684 . . . . 0.55 109.941 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 138' ' ' LYS . 2.6 m-85 -81.21 131.66 35.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.47 -0.769 . . . . 0.89 110.133 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -120.92 116.88 25.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.571 -0.705 . . . . 3.11 110.099 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mmmt 53.02 37.44 24.72 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.398 -0.814 . . . . 4.04 110.678 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' C ' HG23 ' A' ' 137' ' ' VAL . . . 77.39 34.85 39.11 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.587 -1.405 . . . . 1.42 109.587 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.419 HG23 ' C ' ' A' ' 136' ' ' GLY . 58.8 t -147.18 111.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.51 -0.994 . . . . 1.72 110.079 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -63.7 129.87 41.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.552 -0.718 . . . . 2.82 110.206 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pt -115.98 -22.59 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.51 -0.744 . . . . 1.47 110.682 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -170.09 132.81 1.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.268 -0.895 . . . . 2.0 110.645 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 4.2 pttt -141.33 143.61 34.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.571 -0.706 . . . . 2.12 109.912 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 143' ' ' ASP . 37.0 m -139.29 167.66 21.58 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.437 -0.79 . . . . 1.42 110.712 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 142' ' ' THR . 10.0 p-10 -118.68 117.08 27.98 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.67 -0.644 . . . . 2.32 110.125 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -94.95 106.97 19.0 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.464 -0.772 . . . . 1.52 110.426 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.8 ttt -66.24 113.82 4.86 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.528 -0.732 . . . . 2.23 109.61 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 158' ' ' PHE . 54.1 t -79.73 -66.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.552 -0.717 . . . . 0.93 110.059 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.37 173.96 19.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.847 -1.301 . . . . 0.8 109.847 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 85.1 p -83.33 149.82 26.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.676 -0.896 . . . . 1.36 110.07 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.46 ' CE2' HG12 ' A' ' 146' ' ' VAL . 77.9 m-85 -147.55 125.9 12.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.579 -0.701 . . . . 1.26 110.301 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -101.13 147.41 17.76 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.438 -1.465 . . . . 0.71 109.438 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.25 141.0 34.91 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.34 1.179 . . . . 1.05 110.263 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.6 ttt-85 -167.1 -39.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.637 -0.664 . . . . 4.58 110.899 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.37 -75.2 0.43 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 3.07 111.365 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -143.37 -145.0 0.16 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.413 -0.805 . . . . 3.69 110.473 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.435 ' HB3' ' HG2' ' A' ' 117' ' ' ARG . 1.8 pm0 -83.37 -175.07 5.64 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.169 -0.957 . . . . 2.53 111.068 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 51.4 m-85 -127.21 171.83 11.1 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.406 -0.591 . . . . 1.64 109.406 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -123.24 96.99 5.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 2.28 110.96 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.623 ' CD1' HG13 ' A' ' 146' ' ' VAL . 37.9 t80 -76.89 162.04 27.93 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.895 -0.78 . . . . 1.64 108.895 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.5 mt -148.82 124.54 10.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.376 -0.827 . . . . 1.75 110.865 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.472 HG22 ' CE2' ' A' ' 158' ' ' PHE . 42.0 p -102.27 152.53 38.3 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.557 -0.714 . . . . 0.61 109.333 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.54 169.3 16.05 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.584 1.308 . . . . 0.48 110.631 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -57.8 114.81 2.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.654 -0.654 . . . . 2.79 110.808 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -105.22 109.78 21.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.69 . . . . 2.0 109.815 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -66.11 128.92 37.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 2.47 110.501 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.855 ' HB1' ' HD2' ' A' ' 166' ' ' PRO . . . -77.22 -176.83 0.68 Allowed Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.762 -0.586 . . . . 0.61 109.844 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.855 ' HD2' ' HB1' ' A' ' 165' ' ' ALA . 47.5 Cg_endo -75.6 126.27 9.48 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 O-C-N 123.164 1.087 . . . . 0.84 110.247 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 10.6 ptpt -111.06 172.71 6.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.515 -0.741 . . . . 2.29 110.412 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 122.23 156.59 9.72 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.428 -1.469 . . . . 1.7 109.428 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.9 ttt -60.33 -39.78 88.28 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.563 -0.963 . . . . 2.85 110.114 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.776 ' O ' HD23 ' A' ' 170' ' ' LEU . 3.6 tt -82.4 -25.15 33.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.666 -0.646 . . . . 2.55 110.29 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 167' ' ' LYS . . . -58.74 -22.58 58.09 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.524 -0.735 . . . . 0.77 110.72 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -64.88 126.29 27.52 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.379 -0.826 . . . . 2.3 110.008 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 153.08 -178.58 30.08 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.733 -1.347 . . . . 0.47 109.733 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 6.0 p -85.0 137.42 33.09 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.622 -0.928 . . . . 0.48 110.575 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -123.96 103.76 8.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.65 -0.656 . . . . 0.6 110.428 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.34 129.97 41.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.566 -0.709 . . . . 1.52 109.328 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' CG2' ' CG ' ' A' ' 130' ' ' GLN . 25.1 mt -118.58 150.15 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.376 -0.827 . . . . 0.8 110.798 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -119.0 104.74 10.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.621 -0.674 . . . . 2.44 110.199 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 192' ' ' TRP . 1.9 m -104.46 124.31 49.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.578 -0.701 . . . . 1.35 110.169 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -113.93 108.46 17.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.636 -0.665 . . . . 2.46 110.113 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.47 ' CE2' ' CE ' ' A' ' 126' ' ' MET . 1.3 t80 -80.88 104.38 11.35 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.703 -0.623 . . . . 1.58 109.994 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 5.5 t -130.76 -171.8 2.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.61 -0.681 . . . . 1.17 110.353 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.45 -151.18 0.47 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.427 -0.583 . . . . 1.52 109.427 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.24 -49.63 76.33 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.306 -0.871 . . . . 2.87 110.248 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.25 -15.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.914 -0.491 . . . . 5.08 112.074 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.4 -50.1 23.3 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.046 -1.034 . . . . 5.77 111.819 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 8.8 t -175.93 -166.29 0.18 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.731 . . . . 1.46 110.758 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -115.12 125.21 53.2 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.388 -0.597 . . . . 2.59 109.388 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.427 ' CE1' ' HB ' ' A' ' 70' ' ' VAL . 57.9 m-70 -69.31 -56.42 7.58 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.501 -0.75 . . . . 1.83 110.732 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 12.2 tp -168.52 154.6 6.94 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.814 . . . . 1.31 110.444 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.6 p -146.48 142.04 27.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.617 -0.677 . . . . 1.3 109.974 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.579 ' CD2' HD21 ' A' ' 90' ' ' LEU . 24.3 p90 -137.42 -163.89 1.51 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.565 -0.71 . . . . 0.38 110.139 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.66 126.11 7.41 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.536 -0.728 . . . . 2.49 110.545 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.551 ' HZ3' HD13 ' A' ' 196' ' ' LEU . 9.0 p-90 -137.36 146.12 44.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.632 -0.668 . . . . 0.4 109.893 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.08 143.78 25.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.708 -0.62 . . . . 1.28 111.1 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.763 HD11 HD12 ' A' ' 104' ' ' LEU . 17.7 tp -111.26 104.8 13.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.729 -0.607 . . . . 0.77 109.454 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 88.2 m -81.89 107.17 14.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.62 -0.675 . . . . 0.53 110.805 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 48.0 mm -78.81 159.46 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.582 -0.698 . . . . 0.4 109.27 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -154.93 -154.24 0.49 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.41 -0.807 . . . . 2.06 110.369 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -122.85 -34.41 3.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.509 -0.745 . . . . 3.65 111.025 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -143.19 51.56 1.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.308 -0.87 . . . . 2.62 111.772 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TRP . . . . . 0.643 ' CZ3' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -55.27 -21.92 16.4 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.244 -0.91 . . . . 0.82 110.986 179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.31 37.47 1.77 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.442 -0.786 . . . . 3.87 110.054 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.033 -0.984 . . . . 3.74 110.184 -179.875 . . . . . . . . 1 1 . 1 stop_ save_